Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.
This is an On-demand recording from November 2021
Regulations struggle to keep up with rapidly evolving AI-driven solutions in the healthcare field. Characteristics and applications of AI are raising ethical and technological challenges that extend beyond current medical software regulatory framework.
Artificial Intelligence: A Regulatory Perspective will address questions such as:
This live webcast will clarify the terminology and concepts under the umbrella term Artificial Intelligence and how it differs from standard software. Speakers will provide an overview of the regulatory framework on the EU market and analyze current regulatory requirements and limitations under the MDR using real examples of commercialized solutions. Finally, the program will explore the projection of AI and the challenges regulations will face in the near future.
Irene Sanz supports medical device development projects for Novartis. She has been dedicated to the medical devices field for the past five years, working on research and development projects, and as a regulatory consultant for German and Swiss companies. Sanz holds an MSc in biomedical technologies, with a focus on artificial intelligence, from the University Carlos III of Madrid.
Ortzi Olasolo has dedicated most of his career to the design and development of medical devices, a field in which he possesses a strong technical and regulatory background. His current areas of interest are combination products and software as a medical device (SaMD). Olasolo holds an MSc in biomedical technologies from the University of Navarra.